相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Single nucleotide polypmorphisms in ERCC1 are associated with disease progression, and survival in patients with advanced stage ovarian and primary peritoneal carcinoma; A Gynecologic Oncology Group Study
Thomas C. Kriyak et al.
GYNECOLOGIC ONCOLOGY (2011)
Excision repair cross-complementation group 1 protein overexpression as a predictor of poor survival for high-grade serous ovarian adenocarcinoma
Stefanie Scheil-Bertram et al.
GYNECOLOGIC ONCOLOGY (2010)
Profound elevation of CD8+ T cells expressing the intraepithelial lymphocyte marker CD103 (αE/β7 Integrin) in high-grade serous ovarian cancer
John R. Webb et al.
GYNECOLOGIC ONCOLOGY (2010)
Ovarian cancer tumor infiltrating T-regulatory (Treg) cells are associated with a metastatic phenotype
Jason C. Barnett et al.
GYNECOLOGIC ONCOLOGY (2010)
T Cell Density and Location Can Influence the Prognosis of Ovarian Cancer
Ahmad Al-Attar et al.
PATHOLOGY & ONCOLOGY RESEARCH (2010)
Intraepithelial CD8-positive T lymphocytes predict survival for patients with serous stage III ovarian carcinomas: relevance of clonal selection of T lymphocytes
M. Stumpf et al.
BRITISH JOURNAL OF CANCER (2009)
Intraepithelial T Cells and Tumor Proliferation
Sarah F. Adams et al.
CANCER (2009)
Immunodetection of DNA Repair Endonuclease ERCC1-XPF in Human Tissue
Nikhil R. Bhagwat et al.
CANCER RESEARCH (2009)
The DNA repair proteins BRCA1 and ERCC1 as predictive markers in sporadic ovarian cancer
Johanne Weberpals et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
The Relationship of Platinum Resistance and ERCC1 Protein Expression in Epithelial Ovarian Cancer
Karina Dahl Steffensen et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2009)
Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss
Blaise Clarke et al.
MODERN PATHOLOGY (2009)
Excision repair cross-complementation group 1 (ERCC1) in platinum-based treatment of non-small cell lung cancer with special emphasis on carboplatin: A review of current literature
Adam Vilmar et al.
LUNG CANCER (2009)
Expression of excision repair cross-complementation group 1 protein predicts poor outcome in advanced non-small cell lung cancer patients treated with platinum-based doublet chemotherapy
Hyun Woo Lee et al.
LUNG CANCER (2009)
Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors
Katy Milne et al.
PLOS ONE (2009)
Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma
Marketa Tomsova et al.
GYNECOLOGIC ONCOLOGY (2008)
Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancer
K. D. Steffensen et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
Sporadic epithelial ovarian cancer: Clinical relevance of BRCA1 inhibition in the DNA damage and repair pathway
Johanne I. Weberpals et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Relationship between ERCC1 polymorphisms, disease progression, and survival in the gynecologic oncology group phase III trial of intraperitoneal versus intravenous cisplatin and paclitaxel for stage III epithelial ovarian cancer
Thomas C. Krivak et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
CD8+ T cells induce complete regression of advanced ovarian cancers by an Interleukin (IL)-2/IL-15-dependent mechanism
Taimei Yang et al.
CLINICAL CANCER RESEARCH (2007)
ERCC1 genotype and phenotype in epithelial ovarian cancer identify patients likely to benefit from paclitaxel treatment in addition to platinum-based therapy
Stephanie Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
A gynecologic oncology group study of platinum-DNA adducts and excision repair cross-complementation group 1 expression in optimal, stage III epithelial ovarian cancer treated with platinum-taxane chemotherapy
Kathleen M. Darcy et al.
CANCER RESEARCH (2007)
Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy
J. Bellmunt et al.
ANNALS OF ONCOLOGY (2007)
DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy
Ken A. Olaussen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Association between excision repair cross-complementation group 1 polymorphism and clinical outcome of platinum-based chemotherapy in patients with epithelial ovarian cancer
Sokbom Kang et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2006)
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
E Sato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer
D Wolf et al.
CLINICAL CANCER RESEARCH (2005)
Tumour-infiltrating gamma/delta T-lymphocytes are correlated with a brief disease-free interval in advanced ovarian serous carcinoma
MR Raspollini et al.
ANNALS OF ONCOLOGY (2005)
Different mechanisms of cyclin D1 overexpression in multiple myeloma revealed by fluorescence in situ hybridization and quantitative analysis of mRNA levels
K Specht et al.
BLOOD (2004)
Intratumoral CD8+ T lymphocytes as a prognostic factor of survival in endometrial carcinoma
S Kondratiev et al.
CLINICAL CANCER RESEARCH (2004)
Immunophenotyping of tumor-infiltrating mononuclear cells in ovarian carcinoma
TE Helal et al.
PATHOLOGY & ONCOLOGY RESEARCH (2004)
分享论文
